Trade War Expansion? STAR Board Aims To Keep Lucrative China Biotech IPOs At Home

China has officially unveiled its newest stock market for pre-revenue high-tech companies, already attracting ChipScreen and marking a new rival to similar bourses in the US and Hong Kong. But some are cautioning that local regulators and investors will need to step up if the so-called China Nasdaq is to gain traction.

Money Wave
CHIPSCREEN AMONG FIRST BIOPHARMAS TO GO PUBLIC ON SHANGHAI'S NEW STAR BOARD • Source: Shutterstock

More from China

More from Focus On Asia